An enhanced version of an already popular vitamin could offer a "groundbreaking approach" to better combat the disease.
Roughly 7.2 million Americans over the age of 65 are affected by Alzheimer’s disease, according to estimates from the Alzheimer’s Association. Though today’s treatments can slow the disease’s progression and ease symptoms, they don’t replace the cells that are lost. That’s why many researchers are now focused on ways to help the brain regenerate, one strategy being “neuronal differentiation,” a process in which immature cells develop into working neurons.
Now, recent research suggests that a vitamin best known for helping blood clot and supporting bone and liver function may soon have a surprising next act: protecting the brain and even helping it heal itself.
In a July 2025 study conducted by biochemistry researchers in Japan, scientists redesigned vitamin K molecules so they could better support the growth of new brain cells. The lab-made versions detailed in the study were far more powerful than natural vitamin K, showing about three times the ability to turn stem cells into neurons.
Citing how “neuronal loss is a hallmark of neurodegenerative diseases such as Alzheimer’s disease,” study author and bioscience professor Dr. Yoshihisa Hirota says the vitamin K compounds “may serve as regenerative agents that help replenish lost neurons and restore brain function.” The research team also noted that people living with Parkinson’s and Huntington’s disease could also benefit from the treatment.
Vitamin K has already been linked to brain health, but the natural forms may be too weak to make a real difference on their own. To solve this, scientists combined vitamin K with retinoic acid, a compound related to vitamin A that helps guide brain development. The result was a new group of vitamin K hybrids that kept the benefits of both nutrients.
In tests on the neural stem cells of mice, one standout compound triggered neuron growth at levels far higher than standard vitamin K. The team also uncovered how it works: The compound interacts with a brain receptor called mGluR1, which plays a role in nerve cell communication and movement. When this receptor was activated, genes involved in neuron growth switched on.
Animal studies using mice added another promising detail: The new vitamin K compound crossed the blood-brain barrier and led to higher levels of active vitamin K inside the brain than usual forms.
While this research is still early and did not involve human subjects, it points to a future where vitamin K–based drugs could help slow—or possibly even reverse—some of the brain damage seen in Alzheimer’s patients. That possibility offers a rare and hopeful glimpse of progress.
“Our research offers a potentially groundbreaking approach to treating neurodegenerative diseases,” says Dr. Hirota. “A vitamin K-derived drug that slows the progression of Alzheimer’s disease or improves its symptoms could not only improve the quality of life for patients and their families but also significantly reduce the growing societal burden of healthcare expenditures and long-term caregiving.”
Before taking any new supplement, including vitamin K, be sure to speak with your doctor or pharmacist first.
For daily wellness updates, subscribe to The Healthy newsletter and follow The Healthy on Facebook and Instagram. Keep reading:
